These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20276495)

  • 41. [Guillain-Barré syndrome with central nervous system symptoms. Report of two cases].
    Łabuz-Roszak B; Pierzchała K; Kapustecki J; Biernawska J; Mańka I; Kumor K
    Neurol Neurochir Pol; 2004; 38(3):221-6. PubMed ID: 15354236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Data on a case of Guillain-Barré syndrome treated with intraspinal administration of hydrocortisone acetate].
    GROSSI F; BARBIS V
    Clin Ter; 1959 Mar; 16(3):279-84. PubMed ID: 13652431
    [No Abstract]   [Full Text] [Related]  

  • 43. Experience with Guillain-Barré syndrome in a neurological Intensive Care Unit.
    González P; García X; Guerra A; Arango JC; Delgado H; Uribe CS; Sará J; López de Mesa JC; Hernández O
    Neurologia; 2016; 31(6):389-94. PubMed ID: 25542501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Tracheotomy and Percutaneous Endoscopic Gastrostomy in Patients with Guillain-Barré Syndrome.
    Yoshida M; Ikeda J; Urikane Y; Kashiwada T; Kaseda Y; Kohriyama T
    Dysphagia; 2017 Apr; 32(2):236-240. PubMed ID: 27687522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [ACTH and cortisone in the treatment of Guillain-Barré syndrome and other peripheral nervous disorders; preliminary report].
    FERNANDEZ JJ
    Arch Col Med El Salv; 1954 Mar; 7(1):13-9. PubMed ID: 13218944
    [No Abstract]   [Full Text] [Related]  

  • 47. [Barré syndrome and prednisone].
    SCHIAVO AJ
    Prensa Med Argent; 1956 May; 43(20):1615-21. PubMed ID: 13370461
    [No Abstract]   [Full Text] [Related]  

  • 48. [Case of acute Guillain-Barre syndrome].
    Pan P
    Zhongguo Zhen Jiu; 2015 Dec; 35(12):1280. PubMed ID: 26964179
    [No Abstract]   [Full Text] [Related]  

  • 49. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guillain-Barré syndrome in a case of acute lymphoblastic leukaemia. A case report.
    Vembu P; Al-Shubaili A; Al-Khuraibet A; Kreze O; Pandita R
    Med Princ Pract; 2003; 12(4):272-5. PubMed ID: 12966204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of Guillain-Barré syndrome with meningeal irritation.
    Ashikari Y; Kobayashi S; Tago A; Yoneyama M; Ito M; Fukuda K; Mizuno Y; Tsunoda Y; Shimizu S; Yokoi K; Kamioka N; Hamajima N; Suzuki S
    Brain Dev; 2016 Jan; 38(1):163-6. PubMed ID: 26403311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiating Familial Neuropathies from Guillain-Barré Syndrome.
    Bordini BJ; Monrad P
    Pediatr Clin North Am; 2017 Feb; 64(1):231-252. PubMed ID: 27894447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological Drugs in Guillain-Barré Syndrome: An Update.
    Motamed-Gorji N; Matin N; Tabatabaie O; Pavone P; Romano C; Falsaperla R; Vitaliti G
    Curr Neuropharmacol; 2017; 15(7):938-950. PubMed ID: 27964705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanical ventilation in Guillain-Barre syndrome.
    Kumar S
    Neurol India; 2003 Dec; 51(4):559-60; author reply 560. PubMed ID: 14742953
    [No Abstract]   [Full Text] [Related]  

  • 55. New concepts of Guillain-Barré syndrome.
    Asbury AK
    J Child Neurol; 2000 Mar; 15(3):183-91. PubMed ID: 10757475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guillain-Barré syndrome.
    TUPPER CJ; FOSTER RD
    U S Armed Forces Med J; 1954 Apr; 5(4):532-5. PubMed ID: 13146921
    [No Abstract]   [Full Text] [Related]  

  • 57. Guillain-Barré syndrome: 100 years on.
    Créange A
    Rev Neurol (Paris); 2016 Dec; 172(12):770-774. PubMed ID: 27866731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.
    Jasti AK; Selmi C; Sarmiento-Monroy JC; Vega DA; Anaya JM; Gershwin ME
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1175-1189. PubMed ID: 27292311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment for Guillain-Barré syndrome.
    Cornblath DR; Hughes RA
    Ann Neurol; 2009 Nov; 66(5):569-70. PubMed ID: 19938064
    [No Abstract]   [Full Text] [Related]  

  • 60. Guillain-Barré syndrome.
    Arcila-Londono X; Lewis RA
    Semin Neurol; 2012 Jul; 32(3):179-86. PubMed ID: 23117942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.